NCT02703467View on ClinicalTrials.gov

Exhaled Hydrogen Sulphide as a Biomarker of Airways Disease in Asthma

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

August 1, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Asthma
Trial Locations (1)

SW3 6HP

Royal Brompton Hospital, London

All Listed Sponsors
collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

lead

Imperial College London

OTHER

NCT02703467 - Exhaled Hydrogen Sulphide as a Biomarker of Airways Disease in Asthma | Biotech Hunter | Biotech Hunter